Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

June 30, 2017

Conditions
PTSD
Interventions
BEHAVIORAL

Virtual reality exposure therapy

Virtual reality exposure (VRE) therapy is a form of exposure therapy in which participants are helped to confront their traumatic memories in a therapeutic manner. They describe the events out loud and their therapist attempts to match what they are describing in the virtual reality. This is done repeatedly, allowing distress associated with these memories to decrease. Material that emerges during the VRE exposure is processed, or discussed, after the exposure, allowing participants to think about themselves and the event differently.

DRUG

0.5 mg DEX

A dose of DEX will be given the night before (approximately 10 hours before) each of 5 to 11 individual virtual reality exposure (VRE) therapy sessions.

Trial Locations (1)

30306

Emory University, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT01965366 - Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD | Biotech Hunter | Biotech Hunter